N/A
N/A
Both
Voice Quality
Trial Information
early laryngeal cancer is a well known field with great controversy in treatment. two
options are available in treatment of patients the first one is partial laryngectomy and the
second one is radiotherapy.one of major concern of patients have been the quality of voice
as part of quality of life ,so we design this clinical randomised trial to answer the
priority of each options.
Inclusion Criteria:
- Early laryngeal cancer
Exclusion Criteria:
- No history of radiotherapy and collagen vascular disease
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Outcome Measure:
quality of voice
Outcome Time Frame:
3 to 6 month after therapy
Safety Issue:
No
Principal Investigator
babak saedi, professor
Investigator Role:
Principal Investigator
Investigator Affiliation:
tehran university of medical science
Authority:
Iran: TUMS ethics committee
Study ID:
bs-86-01-48-5497
NCT ID:
NCT00497588
Start Date:
March 2007
Completion Date:
December 2012
Related Keywords:
- Voice Quality
- laryngeal cancer
- RADIOTHERAPY
- Voice Quality
- Laryngeal Neoplasms
Name | Location |
|---|
